文献速递瓣膜病与结构性心脏病肺血管病与心包/心肌炎

弯刀综合征自然病史与手术结局:欧洲多中心研究

The natural history and surgical outcome of patients with scimitar syndrome: a multi-centre European study.
PubMed 文献 · Eur Heart J · 2018-01-01

该多中心注册研究纳入485例弯刀综合征患者,其中279例(57%)接受手术,206例(43%)临床监测。30岁时总生存概率为88%(95%CI 85-92),合并先天性心脏病或肺动脉高压者生存更低;手术患者无症状比例更高,但25%出现弯刀引流静脉狭窄/闭塞。

要点

  • 弯刀综合征30岁总生存概率为88%,合并先心病或肺动脉高压者生存更低。
  • 手术患者末次随访无症状比例高于监测患者(73% vs 47%)。
  • 25%手术患者出现弯刀引流静脉狭窄/闭塞,与手术年龄较小相关。

核心结论

  • 弯刀综合征患者总体生存率高,但合并先天性心脏病或肺动脉高压者生存概率降低。
  • 手术治疗有助于减少症状,但术后弯刀引流静脉狭窄/闭塞风险显著,需结合血流动力学评估和年龄个体化决策。

研究设计与样本

  • 多中心注册研究,纳入51家机构的485例弯刀综合征患者,手术组279例(57%),临床监测组206例(43%)。
  • 末次随访中位年龄11.6岁(四分位距4-22岁)。

主要发现

  • 30岁时总生存概率为88%(95%CI 85-92%)。
  • 合并先天性心脏病(P<0.001)和肺动脉高压(P<0.001)者生存概率更低。
  • 末次随访时62%(279/451)患者无症状;手术组无症状比例73%,监测组47%(P<0.001)。
  • 手术组心脏症状风险较低(OR 0.42,95%CI 0.22-0.82),呼吸症状风险较低(OR 0.08,95%CI 0.02-0.28)。
  • 25%(63/254)手术患者出现弯刀引流静脉狭窄/闭塞,与手术年龄较小相关(OR 0.4,95%CI 0.21-0.78)。

临床怎么用

  • 对弯刀综合征患者应评估合并先天性心脏病和肺动脉高压,以识别生存风险较高者。
  • 手术决策需权衡症状改善获益与术后引流静脉狭窄/闭塞风险,结合血流动力学评估和患者年龄个体化制定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Treatment decisions in patients with scimitar syndrome (SS) are often challenging, especially in patients with isolated SS who are often asymptomatic and who might be diagnosed accidentally. We queried a large multi-institutional registry of SS patients to evaluate the natural history of this condition and to determine the efficacy of surgical treatment in terms of survival and clinical status. METHODS AND RESULTS: We collected data on 485 SS patients from 51 institutions; 279 (57%) patients were treated surgically (STPs) and 206 (43%) were clinically monitored (CMPs). Median age at last follow-up was 11.6 years (interquartile range 4-22 years). Overall survival probability at 30 years of age was 88% [85-92% confidence intervals (CI)] and was lower in patients with associated congenital heart disease (CHD) (P < 0.001) and pulmonary hypertension (P < 0.001). Most patients were asymptomatic at last follow-up (279/451, 62%); STPs were more frequently asymptomatic than CMPs (73% vs. 47%, P < 0.001), with fewer cardiac [odds ratio (OR) 0.42, 95% CI 0.22-0.82] and respiratory symptoms (OR 0.08, 95% CI 0.02-0.28). Many STPs (63/254, 25%) had stenosis/occlusion of the scimitar drainage, and this was associated with a younger age at surgery (OR 0.4, CI 0.21-0.78). CONCLUSION: Patients with SS have a high overall survival. Survival probability was lower in patients with associated CHDs and in patients with pulmonary hypertension. Surgical treatment of SS is beneficial in reducing symptoms, however, given the significant risk of post-operative scimitar drainage stenosis/occlusion, it should be tailored to a comprehensive haemodynamic evaluation and to the patient's age.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Vida VL, Guariento A, Milanesi O, et al. The natural history and surgical outcome of patients with scimitar syndrome: a multi-centre European study. Eur Heart J. 2018. PMID: 29029134. doi:10.1093/eurheartj/ehx526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。